Recursion Pharmaceuticals
RXRX
#5297
Rank
NZ$2.79 B
Marketcap
NZ$4.48
Share price
-9.93%
Change (1 day)
-39.69%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): NZ-$1.58

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$1.65. In 2025 the company made an earnings per share (EPS) of NZ-$2.71 an increase over its 2024 EPS that were of NZ-$3.03.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.58-41.76%
2025NZ-$2.71-10.84%
2024NZ-$3.035.73%
2023NZ-$2.8714.6%
2022NZ-$2.5017.39%
2021NZ-$2.13